Free tool
FAERS Monitor: Junior Strength Advil
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020267 or its brand name (Junior Strength Advil, Ibuprofen). Reports on generic versions are filed under their own applications.
Reports
201,373
Serious
146,632
73% of reports
Hospitalization
71,558
Death reported
16,449
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective15,947
- pain15,216
- fatigue14,696
- nausea13,732
- headache12,242
- arthralgia11,062
- dyspnoea10,662
- vomiting10,136
- diarrhoea9,837
- rash9,148
- off label use8,775
- dizziness8,295
- pruritus8,029
- pyrexia7,974
- acute kidney injury6,763
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,609 |
| 2005 | 2,142 |
| 2006 | 2,049 |
| 2007 | 2,110 |
| 2008 | 1,780 |
| 2009 | 2,765 |
| 2010 | 3,972 |
| 2011 | 5,698 |
| 2012 | 7,063 |
| 2013 | 6,774 |
| 2014 | 6,585 |
| 2015 | 9,139 |
| 2016 | 12,507 |
| 2017 | 11,355 |
| 2018 | 15,605 |
| 2019 | 16,698 |
| 2020 | 15,483 |
| 2021 | 15,284 |
| 2022 | 14,651 |
| 2023 | 13,680 |
| 2024 | 12,648 |
| 2025 | 12,810 |
| 2026 | 8,957 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,852,786 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 6,763 | 4.8 | 4.7 | 19,479 |
| arthralgiaSignal | 11,062 | 2.8 | 2.8 | 12,973 |
| painSignal | 15,216 | 2.6 | 2.6 | 15,408 |
| pyrexiaSignal | 7,974 | 2.4 | 2.4 | 6,731 |
| vomitingSignal | 10,136 | 2.3 | 2.2 | 7,282 |
| rashSignal | 9,148 | 2.2 | 2.2 | 6,112 |
| pruritusSignal | 8,029 | 2.2 | 2.2 | 5,287 |
| headacheSignal | 12,242 | 2.1 | 2.0 | 6,748 |
| fatigue | 14,696 | 2.0 | 2.0 | 7,376 |
| dyspnoea | 10,662 | 2.0 | 1.9 | 5,260 |
| nausea | 13,732 | 1.8 | 1.8 | 5,243 |
| dizziness | 8,295 | 1.7 | 1.7 | 2,682 |
| diarrhoea | 9,837 | 1.6 | 1.6 | 2,253 |
| drug ineffective | 15,947 | 1.3 | 1.2 | 946 |
| off label use | 8,775 | 1.0 | 1.0 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.